JENA LEISHER: Open Payments
NPI 1831737519 · LANCASTER, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,324 in 57 payments from 9 companies in 2025. Trend: 2023 $1,324 · 2024 $967 · 2025 $1,324
Food & beverage: $1,324
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 12 | $269 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $234 |
| ABBVIE INC. | 9 | $185 |
| Supernus Pharmaceuticals, Inc. | 6 | $166 |
| Alkermes, Inc. | 9 | $151 |
| Neurocrine BioSciences, Inc. | 4 | $122 |
| Axsome Therapeutics, Inc. | 3 | $93 |
| Lundbeck LLC | 3 | $68 |
| Collegium Pharmaceutical, Inc. | 2 | $36 |
Products named: CAPLYTA, VRAYLAR, ABILIFY MAINTENA, Qelbree, LYBALVI, INGREZZA, REXULTI, Auvelity.
Industry payments across PA — which companies pay providers there.
